GlassScriptPhysician profile
Amanuel Sima
NPI 1366493744
$856.46
in general payments reported to CMS, 2019-2025
14 companies · $19.61 in 2025
The $19.61 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $458 · 2022: $38.66 · 2023: $40.34 · 2024: $14.56 · 2025: $19.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $74.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $74.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $165.90 | 2019-2020 | |
| Advanced Respiratory, INC | $125.08 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $109.97 | 2020 | |
| Glaxosmithkline, LLC. | $67.78 | 2019-2024 | Trelegy Ellipta |
| Harmony Biosciences LLC | $64.30 | 2022-2023 | Wakix |
| Astrazeneca Pharmaceuticals LP | $64.27 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $58.48 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $49.39 | 2019 | |
| Genzyme Corporation | $43.66 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $23.15 | 2020 | |
| Mylan Specialty L.P. | $22.21 | 2020 | |
| Horizon Therapeutics Plc | $21.81 | 2020 | |
| Pfizer INC. | $20.95 | 2019 | |
| Genentech USA, INC. | $19.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanuel Sima listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.